Higher Trough Vedolizumab Concentrations During Maintenance Therapy are Associated With Corticosteroid-Free Remission in Inflammatory Bowel Disease

BACKGROUND AND AIMS: Vedolizumab is an anti-α4β7 biologic approved for ulcerative colitis [UC] and Crohn’s disease [CD]. We aimed to examine the association of maintenance vedolizumab concentrations with remission. METHODS: We performed a cross-sectional multi-centre study of inflammatory bowel dise...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Crohns Colitis
Main Authors: Ungaro, Ryan C, Yarur, Andres, Jossen, Jacqueline, Phan, Becky L, Chefitz, Ezra, Sehgal, Priya, Kamal, Kanika, Bruss, Alexandra, Beniwal-Patel, Poonam, Fox, Caroline, Patel, Amir, Bahur, Bayda, Jain, Anjali, Stein, Daniel, Naik, Snehal, Dubinsky, Marla C
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7185193/
https://ncbi.nlm.nih.gov/pubmed/31087100
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ecco-jcc/jjz041
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados